Hipertensión arterial

enero 4, 2010

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.

Filed under: Ensayo clinico — Jorge Luis León Alvarez @ 9:12 am

lancet-2009-a-selective-endothelin-eceptor-antagonist-to-reduce-blood-pressure-in-patients-with-treatment-resistant-hypertension-a-randomised-double-blind-placebo-controlled-trialPor: Michael A Weber, Henry Black, George Bakris, Henry Krum, Stuart Linas, Robert Weiss, Jennifer V Linseman, Brian L Wiens, Marshelle S Warren y Lars H Lindholm. www.thelancet.com Published online September 14, 2009.

No hay comentarios

Aún no hay comentarios.

Suscripción RSS a los comentarios de esta entrada.

Disculpa, los comentarios están cerrados.

Autor: Jorge Luis León Alvarez | Contáctenos
Hipertensión arterial